13F Data
13F filer · CIK 1848809

Velan Capital Investment Management LP

ALPHARETTA, GA · filing since Q4 2021 · last filing Aug 14, 2026
Reported value
$164.2M
+$4.6M vs prior
Positions
51
New / sold out
7 / 5
Added / reduced
10 / 11
Turnover
9.2%
buys $14.9M · sells $18.8M
Top-10 weight
74.8%

Biggest buys vs Q1 2026

ChangeSecurityShares changeChange %Est. trade value
AddedIMMIX BIOPHARMA INC+345,000+46.6%+$3.6M
NewC4 THERAPEUTICS INC+570,000–+$2.7M
AddedAVALO THERAPEUTICS INC+139,330+75.3%+$2.6M
NewADMA BIOLOGICS INC+250,000–+$2.1M
NewREIN THERAPEUTICS INC+1,700,000–+$1.8M
NewTENAX THERAPEUTICS INCCALL+68,700–+$999.6K
AddedNEUMORA THERAPEUTICS INC.+150,000+187.5%+$255.0K
NewTECTONIC THERAPEUTIC INC+6,000–+$206.3K
NewAN2 THERAPEUTICS INC+40,000–+$193.6K
NewSCYNEXIS INC+40,000–+$162.8K
7 more rows. Subscribe for $29/month to see every row, download the data and use the API.

Biggest sells vs Q1 2026

ChangeSecurityShares changeChange %Est. trade value
Sold outESPERION THERAPEUTICS INC NE-1,720,000-100.0%$-4.7M
ReducedPRAXIS PRECISION MEDICINES I-12,000-11.9%$-4.0M
ReducedCYTOMX THERAPEUTICS INC.-420,000-77.8%$-1.6M
ReducedABIVAX SA-11,370-14.8%$-1.5M
ReducedVIRIDIAN THERAPEUTICS INC-81,123-89.0%$-1.5M
ReducedINSPIREMD INC-1,951,514-92.9%$-1.4M
Sold outKAZIA THERAPEUTICS LTD-135,315-100.0%$-1.0M
ReducedROCKET PHARMACEUTICALS INC-234,643-79.6%$-802.5K
ReducedPROFOUND MED CORP-115,432-40.4%$-767.6K
ReducedTENAX THERAPEUTICS INC-33,348-5.7%$-485.2K
6 more rows. Subscribe for $29/month to see every row, download the data and use the API.

Estimated trade value = change in shares × this quarter's implied price. 13F filings show quarter-end positions, not individual trades.

Reported value by quarter

Q4 2021: $128.9MQ1 2022: $107.8MQ2 2022: $98.6MQ3 2022: $100.8MQ4 2022: $113.2MQ1 2023: $117.3MQ2 2023: $107.7MQ3 2023: $124.0MQ4 2023: $171.3MQ1 2024: $220.2MQ2 2024: $174.6MQ3 2024: $106.9MQ4 2024: $115.9MQ1 2025: $97.2MQ2 2025: $101.2MQ3 2025: $106.5MQ4 2025: $172.4MQ1 2026: $159.6MQ2 2026: $164.2M
Q4 2021Q2 2026

Holdings · Q2 2026

#SecuritySharesValueWeight
1PRAXIS PRECISION MEDICINES ICOM NEW88,781$29.7M18.10%
2MAPLIGHT THERAPEUTICS INCCOM492,893$17.7M10.76%
3SUTRO BIOPHARMA INCCOM SHS512,160$17.0M10.36%
4IMMIX BIOPHARMA INCCOM1,085,000$11.2M6.81%
5PROTARA THERAPEUTICS INCCOM STK2,844,652$10.9M6.62%
6ABIVAX SASPONSORED ADS65,630$8.7M5.33%
7TENAX THERAPEUTICS INCCOM NEW549,985$8.0M4.87%
8ANTERIS TECHNOLOGIES GLOBALCOM700,000$6.9M4.20%
9EDESA BIOTECH INCCOM NEW827,500$6.7M4.10%
10EVOMMUNE INCCOM SHS451,255$6.0M3.65%
41 more rows. Subscribe for $29/month to see every row, download the data and use the API.